Annual report pursuant to Section 13 and 15(d)

Organization and Significant Accounting Policies (Details)

v3.24.0.1
Organization and Significant Accounting Policies (Details)
gal in Millions
 12 Months Ended
Dec. 31, 2023
USD ($)
shares
gal
Dec. 31, 2022
USD ($)
shares
Dec. 31, 2021
USD ($)
shares
Sep. 12, 2022
USD ($)
Organization and Significant Accounting Policies (Details) [Line Items]        
Production capacity (in US Gallons) | gal 350.0      
Allowance for credit losses $ 85,000 $ 105,000    
Allowance for Loan and Lease Loss, Recovery of Bad Debts 427,000 (217,000) $ 158,000  
Bad debt recovery     158,000  
Inventory net of valuation adjustments 2,201,000 4,612,000    
Inventory amount 52,611,000 66,628,000    
Fair value assessment of impairment loss 6,544,000 3,100,000  
Amortization of deferred financing costs 1,048,000 177,000 $ 778,000  
Unamortized financing cost $ 4,700,000 $ 5,034,000    
Conserve capital, percentage 50.00%      
Incremental Common Shares Attributable to Dilutive Effect of Written Put Options (in Shares) | shares 981,000 964,000 964,000  
Weighted-average antidilutive shares (in Shares) | shares   3,188,000 8,900,500  
Cash received $ 2,812,000 $ 22,652,000    
Amount allocated to support market losses 700,000,000      
Authorized value 5,000,000     $ 50,000,000
Additional lender value 5,000,000      
Purchase additional amount $ 10,000,000      
Shares repurchased (in Shares) | shares 1,685,000 351,000    
Amount of stock repurchased in cash $ 3,674,000 $ 1,325,000    
Shares of nonvoting common stock (in Shares) | shares 75,703,100 75,154,495    
Equity Method Investment [Member]        
Organization and Significant Accounting Policies (Details) [Line Items]        
Ownership percentage 100.00%      
Accounts Receivable [Member]        
Organization and Significant Accounting Policies (Details) [Line Items]        
Accounts receivable total amount $ 4,302,000 $ 10,469,000    
Inventories [Member]        
Organization and Significant Accounting Policies (Details) [Line Items]        
Inventory amount $ 41,041,000 $ 43,484,000    
Initial Purchase [Member]        
Organization and Significant Accounting Policies (Details) [Line Items]        
Authorized value       $ 10,000,000
Other Customer [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]        
Organization and Significant Accounting Policies (Details) [Line Items]        
Concentration risk percentage 7.00% 15.00%    
Goodwill [Member]        
Organization and Significant Accounting Policies (Details) [Line Items]        
Fair value assessment of impairment loss $ 6,000,000      
Minimum [Member]        
Organization and Significant Accounting Policies (Details) [Line Items]        
Estimated lives 10 years      
Maximum [Member]        
Organization and Significant Accounting Policies (Details) [Line Items]        
Estimated lives 12 years      
Kinergy [Member]        
Organization and Significant Accounting Policies (Details) [Line Items]        
Collateral under line of credit $ 51,315,000 $ 55,667,000    
Agriculture product [Member]        
Organization and Significant Accounting Policies (Details) [Line Items]        
Production capacity (in US Gallons) | gal 1.6      
Nonvoting Common Stock [Member]        
Organization and Significant Accounting Policies (Details) [Line Items]        
Shares of nonvoting common stock (in Shares) | shares 896 896    
Shares of nonvoting common stock outstanding (in Shares) | shares 896,000      
Nonvoting Common Stock [Member] | Common Stock [Member]        
Organization and Significant Accounting Policies (Details) [Line Items]        
Shares of nonvoting common stock (in Shares) | shares 3,539,236      
Suppliers [Member] | Collective Bargaining Arrangement [Member] | Supplier Concentration Risk [Member]        
Organization and Significant Accounting Policies (Details) [Line Items]        
Concentration risk percentage 44.00%      
Assets [Member]        
Organization and Significant Accounting Policies (Details) [Line Items]        
Fair value assessment of impairment loss $ 574,000 $ 0 $ 3,100,000